ArticleGenes & genomics2026
KIF18A knockdown enhances oxidative phosphorylation, suggesting a metabolic basis for antiviral activity against influenza A virus.
Article in Genes & genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundInfluenza A virus (IAV) infection remains a major global health burden, underscoring the need to identify novel host-directed antiviral mechanisms. KIF18A, a kinesin-8 family motor protein, has emerged as a proviral host factor that supports IAV replication, and its pharmacological inhibition suppresses viral infection. However, the transcriptional and metabolic processes underlying this antiviral effect remain incompletely understood.
objectiveWe aimed to characterize the transcriptional consequences of KIF18A knockdown in IAV-infected cells and identify metabolic pathways potentially associated with its antiviral activity.
methodsKIF18A expression was silenced in HEK293T cells by transfection with KIF18A-targeting small interfering RNA. Transcriptomic profiling was performed by RNA sequencing, followed by differential expression and gene set enrichment analyses. Mitochondrial respiratory function was evaluated using the Seahorse XFp Mito Stress assay.
resultsKIF18A knockdown induced extensive transcriptomic remodeling in IAV-infected cells without activating canonical antiviral gene programs. Gene set enrichment analysis of the MSigDB Hallmark collection identified oxidative phosphorylation as the second most significantly enriched pathway. This enrichment was evident in both IAV-infected and non-infected cells, indicating that oxidative phosphorylation upregulation is an intrinsic response to KIF18A depletion rather than a virus-specific effect. Among electron transport chain components, genes encoding Complex Ⅴ ATP synthase subunits exhibited the most consistent upregulation. Concordantly, Seahorse analysis showed significant increases in basal and ATP-linked respiration in siKIF18A cells, without a corresponding increase in proton leak.
conclusionKIF18A knockdown intrinsically upregulates oxidative phosphorylation and enhances mitochondrial ATP-coupled respiration at both the transcriptional and functional levels, implicating metabolic reprogramming as a candidate mechanism contributing to KIF18A knockdown-mediated antiviral activity against IAV.
Indexed as
Identifiers
42804149What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.